Clinical Trials Logo

Stomach Neoplasms clinical trials

View clinical trials related to Stomach Neoplasms.

Filter by:

NCT ID: NCT02090153 Completed - Gastric Cancer Clinical Trials

Study of S-1 Plus LV for Advanced Gastric Cancer

Start date: July 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of S-1 plus Leucovorin (1 week on and 1 week off) as first-line treatment for patients with metastatic and recurrent gastric cancer.

NCT ID: NCT02085031 Recruiting - Stomach Neoplasms Clinical Trials

Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer

Start date: April 2014
Phase: Phase 2
Study type: Interventional

- To date, Roux-en-Y esophagojejunostomy transabdominal extracorporeally by circular stapler was the most common used method during laparoscopy-assisted total gastrectomy for gastric cancer, even though it was not totally laparoscopic surgery in which intracorporeal anastomosis should be performed. - To gain potential clinical benefits from a smaller length of minilaparotomy and an easier anastomosis technique than extracorporeal anastomosis, intracorporeal Roux-en-Y anastomosis using a transorally inserted anvil (OrVilâ„¢) during totally laparoscopic total gastrectomy was adopted by experienced surgeons recently. - However, the safety of intracorporeal Roux-en-Y esophagojejunostomy using a transorally inserted anvil (OrVilâ„¢) has not yet been evaluated. Thus, the study comparing the safety of intracorporeal versus extracorporeal Roux-en-Y esophagojejunostomy by circular stapler based on a well designed randomized controlled trial is needed.

NCT ID: NCT02080650 Completed - Prostate Cancer Clinical Trials

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

Start date: March 2014
Phase: N/A
Study type: Interventional

This pilot study will aim to determine whether circulating tumor cells (CTCs) can be captured using the novel cMET based ferrofluid. The primary objective of this pilot study will be to describe the numbers of c-MET expressing cells that can be detected by the c-MET CTC capture technique. These data will be separated by disease site. The investigator will also describe the detection rates of both the c-MET CTC capture and the EpCAM CTC capture techniques in each patient, also separated by disease site.

NCT ID: NCT02078843 Terminated - Clinical trials for Gastroenteropancreatic Neuroendocrine Tumors

Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors

GaIN
Start date: March 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The investigators hypothesize that the new imaging method Gallium-68-DOTATATE has a higher diagnostic value in the detection of neuroendocrine tumors than the established imaging method Indium-111-Octreoscan. Therefore, the investigators will perform both imaging procedures in patients with suspected or confirmed neuroendocrine tumors. Subsequently, the investigators will compare the diagnostic performance of both methods.

NCT ID: NCT02078700 Completed - Lung Cancer Clinical Trials

Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.

Start date: July 2013
Phase: Phase 2
Study type: Interventional

The objective of this phase 2 study is to evaluate the feasibility of an early palliative care intervention for metastatic cancer patients. Feasibility will be assessed in terms of percentage of patients that accept the proposal of the early palliative care intervention and that effectively start to be followed in the palliative care out-patient clinic. The study will be performed in a consecutive series of newly diagnosed patients affected by lung cancer (NSCLC or SCLC, stage IIIb, IV), mesothelioma (stage II, IV), pancreas (stage IV), stomach (stage IIIb-IV).

NCT ID: NCT02078362 Recruiting - Gastric Cancer Clinical Trials

ADCC Against Gastric Cancer Cells

Start date: September 2013
Phase: N/A
Study type: Observational

Peripheral blood will be taken from the enrolled patients at National University Hospital and from healthy volunteers. ADCC assay will be performed for evaluating efficacy of new medicine candidates.

NCT ID: NCT02076594 Terminated - Clinical trials for Metastatic Gastric Cancer

Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer

Start date: January 2013
Phase: Phase 3
Study type: Interventional

This is a randomized, parallel group, non-blinded phase III trial. Patients with advanced (locoregional or metastatic) gastric cancer not previously treated with chemotherapy for this stage will be randomized in a 1:1 ratio to receive low-TOX (arm A) or EOX (arm B). Randomization will be stratified by performance status (ECOG 0, 1 and 2).

NCT ID: NCT02074124 Completed - Gastric Cancer Clinical Trials

CT Perfusion Changes in GI Cancer During Adenosine Vasodilation Test

Start date: October 2012
Phase: N/A
Study type: Observational

The aim of this study was to investigate changes in abdominal tissue perfusion during adenosine vasodilation. Our hypotheses were that CT perfusion measurements are altered by changes in the circulatory system mediated by adenosine, and a more differentiated assessment of the circulatory capacity of abdominal tumours could be achieved by sequential rest and adenosine vasodilation CT perfusion measurements.

NCT ID: NCT02072317 Recruiting - Clinical trials for Advanced Gastric Cancer

Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer

Start date: November 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate and compare safety and effectiveness of Chemotherapy in Paclitaxel plus raltitrexed plug compare with taxol second-line treatment for advanced gastric cancer

NCT ID: NCT02071043 Completed - Clinical trials for Advanced Gastric Cancer

Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis

Start date: November 2008
Phase: Phase 2
Study type: Interventional

Gastric cancer with para-aortic lymph node (PAN) involvement is regarded as advanced disease, and only chemotherapy is recommended from the guidelines. In unresectable cases, neoadjuvant chemotherapy could prolong survival if conversion to resectability could be achieved.